US to Boost Stockpile of New Drug for COVID-19 to 3.1Mln Doses

WASHINGTON (Sputnik) - The Biden administration will purchase an additional 1.4 million doses of molnupiravir, an oral antiviral medicine that prevents hospitalization by attacking the novel coronavirus in early states of the disease, developers Merck and Ridgeback Biotherapeutics said on Tuesday.